Improved CNS Control With the Addition of Chemotherapy to Osimertinib-A Devil's Bargain?
J Clin Oncol
.
2024 Apr 3:JCO2302699.
doi: 10.1200/JCO.23.02699.
Online ahead of print.
Authors
Yao Yu
1
,
Emily Miao
1
,
Luke R G Pike
1
Affiliation
1
Memorial Sloan Kettering Cancer Center, New York, NY.
PMID:
38569123
DOI:
10.1200/JCO.23.02699
No abstract available
Publication types
Letter